China In-Licensing Model Still Has Profitable Legs: LianBio CEO

 
• By Dexter Jie Yan
  
sales ramp-up
LianBio girds loins for plunge into Asian hypertrophic cardiomyopathy market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia